extracorporeal
- Extracorporeal photopheresis (ECP) is a leukapheresis-based therapeutic procedure that has been approved by the US Food and Drug Administration (FDA) for the treatment of advanced cutaneous T-cell lymphoma (CTCL) since 1988. (medscape.com)
- Extracorporeal photopheresis (ECP) involves the collection of white blood cells with subsequent exposure to a photosensitizer, 8-methoxypsoralen (8-MOP), and ultraviolet A (UVA) radiation. (medscape.com)
- There has been much speculation and research performed on the mechanism of action of extracorporeal photopheresis (ECP). (medscape.com)
- The purpose of this study is to evaluate the safety and effectiveness of extracorporeal photopheresis therapy when added to standard drug therapies administered to patients with moderate to severe chronic graft-versus-host disease. (clinicaltrials.gov)
- Patients with cGVHD who meet entry criteria for the study will be randomly assigned to receive standard of care treatment for 26 weeks or standard or care treatment with extracorporeal photopheresis (ECP) for 26 weeks. (clinicaltrials.gov)
GVHD
- Albany, NY -- ( SBWIRE ) -- 09/21/2016 -- Photopheresis is a type of apheresis, which is a popular therapeutic option used in treatment of various autoimmune diseases, solid organ transplant rejections such as kidney and liver, acute and chronic graft versus host disease (GVHD), and advanced cutaneous T-cell lymphoma. (sbwire.com)
cutaneous
- Photopheresis works in treating cutaneous T-cell lymphoma by signaling the immune system to attack the cancer cells. (utah.edu)
ultraviolet light
- Photopheresis is a procedure that uses ultraviolet light to adjust the immune system. (utah.edu)
Graft
- Photopheresis works in graft-versus-host disease by changing the immune system so it stops attacking the body. (utah.edu)
patient's
- During photopheresis, a technician draws some of the patient's blood and separates it into red blood cells, white blood cells, and platelets. (utah.edu)
Benefit
- Ranran Zhang and William Nicholas Rose, "Photopheresis Provides Significant Long-Lasting Benefit in Nephrogenic Systemic Fibrosis," Case Reports in Dermatological Medicine , vol. 2017, Article ID 3240287, 4 pages, 2017. (hindawi.com)
- It was the occasion to bring together Photopheresis users in order to share experiences and benefit from their expertise. (macopharma.com)
BACKGROUND
- BACKGROUND: Photopheresis was evaluated as a means of preventing restenosis on the basis of immune modulation. (biomedsearch.com)
randomized trial
- Non-pharmacologic prophylactic immunosuppression with photopheresis has also been tested in a prospective, multicenter, randomized trial. (biomedcentral.com)
products
- Transparency Market Research Report Added 'Photopheresis Products Market' to its database. (sbwire.com)
- In addition, photopheresis products have also been found to be applicable in some other diseases as well, including multiple sclerosis, rheumatoid arthritis, psoriasis, and nephrogenic systemic fibrosis. (sbwire.com)
Among
- Among all other segments of this industry, photopheresis represents the fastest growing market since the past few years. (sbwire.com)